Heavy Metal Poisoning

Reversing Chronic Crohn's and Colitis Summit: The Path to Holistic Gut Healing

Retrieved on: 
Friday, February 16, 2024
CNC, Root cause analysis, Knowledge, Health, Gastroesophageal reflux disease, Heavy Metal Poisoning, Interview, Toxicity, Hope, Certification, Patient

CARLSBAD, Calif., Feb. 16, 2024 /PRNewswire/ -- DrTalks, a pioneering platform dedicated to advancing health, wellness, and medicine knowledge, is proud to announce the Reversing Chronic Crohn's and Colitis Summit. This groundbreaking virtual event serves as a platform for people grappling with chronic gut issues to gain insights into alternative treatments, root cause analysis, and holistic healing strategies that go beyond conventional medicine.

Key Points: 
  • The Reversing Chronic Crohn's and Colitis Summit is a premier virtual event that provides hope, knowledge, and support for people struggling with chronic gut conditions.
  • CARLSBAD, Calif., Feb. 16, 2024 /PRNewswire/ -- DrTalks , a pioneering platform dedicated to advancing health, wellness, and medicine knowledge, is proud to announce the Reversing Chronic Crohn's and Colitis Summit .
  • It will be hosted by a gut health expert who has overcome her own struggles with chronic gut conditions: Sinclair Kennally, CNHP, CNC .
  • She is set to interview dozens of experts in chronic gut conditions to discuss how to treat their root causes through holistic approaches.

ICP MS System Market to Cross USD 599.4 million by 2031, Garnering a 4.6% CAGR from 2023 to 2031: TMR Report

Retrieved on: 
Monday, November 6, 2023
Biomedical Research, Element, Food safety, Heavy Metal Poisoning, Biomarker, Food, ICP, Pollution, Research, Application, Drug development, Growth, Isotope, Soil, MS, Pharmacy, Key, Nutrient, Market, Pharmaceutical industry, Oil shale, Lithium

WILMINGTON, Del., Nov. 6, 2023 /PRNewswire/ -- The global ICP MS system market was estimated to have acquired US$ 391.3 million in 2022. It is anticipated to register a 4.6% CAGR from 2023 to 2031 and by 2031, the market is likely to gain US$ 599.4 million.  

Key Points: 
  • By Application, the pharmaceutical and biomedical research segment is expected to accelerate the demand for ICP MS system.
  • ICP MS systems are employed in clinical and medical research for analyzing biomarkers, heavy metal poisoning, and trace element diagnostics, which has created a new market segment for ICP MS.
  • Global Market for ICP MS System: Regional Outlook
    Various reasons are propelling the growth of the ICP MS System market in different regions.
  • Global ICP MS System Market: Key Players
    The following companies are well known participants in the global ICP MS system market:
    Advion Inc. (Beijing Bohui Innovation Biotechnology Co., Ltd.)

ICP MS System Market to Cross USD 599.4 million by 2031, Garnering a 4.6% CAGR from 2023 to 2031: TMR Report

Retrieved on: 
Monday, November 6, 2023
Biomedical Research, Element, Food safety, Heavy Metal Poisoning, Biomarker, Food, ICP, Pollution, Research, Application, Drug development, Growth, Isotope, Soil, MS, Pharmacy, Key, Nutrient, Market, Pharmaceutical industry, Oil shale, Lithium

WILMINGTON, Del., Nov. 6, 2023 /PRNewswire/ -- The global ICP MS system market was estimated to have acquired US$ 391.3 million in 2022. It is anticipated to register a 4.6% CAGR from 2023 to 2031 and by 2031, the market is likely to gain US$ 599.4 million.  

Key Points: 
  • By Application, the pharmaceutical and biomedical research segment is expected to accelerate the demand for ICP MS system.
  • ICP MS systems are employed in clinical and medical research for analyzing biomarkers, heavy metal poisoning, and trace element diagnostics, which has created a new market segment for ICP MS.
  • Global Market for ICP MS System: Regional Outlook
    Various reasons are propelling the growth of the ICP MS System market in different regions.
  • Global ICP MS System Market: Key Players
    The following companies are well known participants in the global ICP MS system market:
    Advion Inc. (Beijing Bohui Innovation Biotechnology Co., Ltd.)

FOURTH GEORGIAN PRESIDENT GIORGI MARGVELASHVILI LEADS COALITION EFFORT TO SAVE FORMER PRESIDENT SAAKASHVILI'S LIFE

Retrieved on: 
Monday, February 6, 2023
Public defender, Justice, Life, Government, DBA, Foreign Affairs, Torture, Mikheil Saakashvili, Poisoning, Former, Parliament, Health, United States Department of Justice, Death, Public Defender of Georgia, Heavy Metal Poisoning, Drug

TBILISI, Georgia, Feb. 6, 2023 /PRNewswire/ -- Amid growing international concerns regarding the rapidly deteriorating health of Former President Saakashvili from possible heavy metal poisoning and torture, and emphasizing the responsibility of the current ruling Georgian Dream Party for his well-being and medical care, Georgia's Fourth President Giorgi Margvelashvili, together with over 150 former and current politicians and thought leaders have issued the following statement:  

Key Points: 
  • "We have seen a number of credible reports that he has been a victim of severe human rights abuses, and misuse of the justice system.
  • However, we are not arguing here, whether Mr. Saakashvili is lawfully imprisoned or not.
  • If anything is to happen to President Saakashvili, the responsibility for violating his health, dignity and life, will be solely with Georgia's current government."
  • "President Saakashvili's death by inhuman treatment in a Georgian prison cell will have extremely harmful internal and external political consequences for Georgia, and will deepen the current polarization in the country.

FOURTH GEORGIAN PRESIDENT GIORGI MARGVELASHVILI LEADS COALITION EFFORT TO SAVE FORMER PRESIDENT SAAKASHVILI'S LIFE

Retrieved on: 
Monday, February 6, 2023
Public defender, Justice, Life, Government, DBA, Foreign Affairs, Torture, Mikheil Saakashvili, Poisoning, Former, Parliament, Health, United States Department of Justice, Death, Public Defender of Georgia, Heavy Metal Poisoning, Drug

TBILISI, Georgia, Feb. 6, 2023 /PRNewswire/ -- Amid growing international concerns regarding the rapidly deteriorating health of Former President Saakashvili from possible heavy metal poisoning and torture, and emphasizing the responsibility of the current ruling Georgian Dream Party for his well-being and medical care, Georgia's Fourth President Giorgi Margvelashvili, together with over 150 former and current politicians and thought leaders have issued the following statement:  

Key Points: 
  • "We have seen a number of credible reports that he has been a victim of severe human rights abuses, and misuse of the justice system.
  • However, we are not arguing here, whether Mr. Saakashvili is lawfully imprisoned or not.
  • If anything is to happen to President Saakashvili, the responsibility for violating his health, dignity and life, will be solely with Georgia's current government."
  • "President Saakashvili's death by inhuman treatment in a Georgian prison cell will have extremely harmful internal and external political consequences for Georgia, and will deepen the current polarization in the country.

U.S. MEDICAL EXPERTS CONFIRM POLITICAL PRISONER, MIKHEIL SAAKASHVILI, HAS BEEN TORTURED AND POISONED WHILE IMPRISONED

Retrieved on: 
Thursday, December 1, 2022
Heavy Metal Poisoning, Even and odd functions, United States Department of Justice, DBA, Mercury, Prefrontal cortex, Risk, Brain, Mortality, Arsenic, FACS, Disease, Health, Justice, White matter, Former, Pharmaceutical industry, Medical device, Torture, Poisoning

TBILISI, Ga., Dec. 1, 2022 /PRNewswire/ -- Amid concerns of rapidly deteriorating health and citing severe human rights abuses, including torture and heavy metal poisoning, an independent team of U.S. medical experts has announced the findings of their recent assessment of the Former President of Georgia, Mikheil Saakashvili.

Key Points: 
  • "His life is immediately threatened unless he is moved to a western treatment facility to receive lifesaving care," added Dr. Cobey.
  • Since President Saakashvili was detained in October 2021, his physical and mental condition has significantly deteriorated.
  • The recent findings confirm he now suffers from debilitating psychological, neurological, orthopedic and gastrointestinal conditions directly caused by confinement.
  • This material is distributed by GP International LLC (DBA GlobalPoint International) for Giulia Alasania on behalf of Mikheil Saakashvili.

OceanTech Acquisitions I Corp. and Captura Biopharma, Inc. Announce Signing of Definitive Business Combination Agreement

Retrieved on: 
Wednesday, August 10, 2022
Biotechnology, Retail, Transportation, Health, Travel, Maritime, Pharmaceutical, Luxury, Transport, Research, Vacation, Cruise, General Health, Science, U.S. Securities and Exchange Commission, Survival, Tripura Merger Agreement, Risk, Americium, CEO, Name, Business architecture, Form, Failure, SEC, 100,000, Investment, Board, Communication, Gadolinium, Lead, Securities Act of 1933, Board of directors, Nelson Mullins Riley & Scarborough, Industry, Sale, Lead poisoning, Nasdaq, Heavy Metal Poisoning, Water, Registration statement, Ix, Person, Combination company, Mergers and acquisitions, Forward-looking statement, Growth, COVID, Prospectus, Incidence, Hospital, Proxy, Acquisition, Solution, Annual report, NIH, Population, BARDA, Business, Xi, Plutonium, Founder, Review, Potassium, Register, PIPE, Form S-4, SPAC, Intention, IPO, Adoption, Pharmaceutical industry, Financial services, Asphalt, Renewable energy, Security (finance), Financial adviser, Risk management, C2E2

We are excited to partner with the team at Captura Biopharma and we believe this business combination will allow a well-capitalized platform to quickly scale its business in multiple markets.

Key Points: 
  • We are excited to partner with the team at Captura Biopharma and we believe this business combination will allow a well-capitalized platform to quickly scale its business in multiple markets.
  • OceanTech is sponsored by OceanTech Acquisitions I Sponsors LLC, an affiliate of investor and entrepreneur Joseph Adir.
  • After the Form S-4 has been filed and declared effective, OceanTech will mail a definitive proxy statement, when available, to its stockholders.
  • Additionally, OceanTech will file other relevant materials with the SEC in connection with the Business Combination.

Heavy Metal Poisoning Drugs in Development 2022, by Stages, Target, MoA, RoA, Molecule Type and Key Players - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 22, 2022
Health, Pharmaceutical, Molecule, Discovery, Heavy Metal Poisoning, R, Therapy, Decision-making, Metal, Mall of America, Heavy metal, Research, Company, News, SEC, History, Target, Toxicology, Fine chemical, Pharmaceutical industry, Medical device, Oil

The "Heavy Metal Poisoning Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Heavy Metal Poisoning Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
  • The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects.
  • The pipeline guide reviews key companies involved in Heavy Metal Poisoning (Toxicology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Heavy Metal Poisoning (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.